Celanese Corporation
CECelanese Corporation’s revenue for fiscal 2025 (year ended December 2025) was $9.5 billion, down 7.05% from fiscal 2024.
- Revenue
- +5.66%
- EPS
- n/m
- Free cash flow
- +22.5%
- Total debt
- −10.2%
Quarter to September 2026, against a year earlier
Follow CE
Alert me
Celanese Corporation (CE) EPS (diluted)
Celanese Corporation's EPS (diluted) for fiscal 2025 was −$10.64, compared with −$13.93 in fiscal 2024. Over the twelve months to 30 September 2026 it was $2.37. Over the past ten years it has ranged from −$13.93 (fiscal 2024) to $17.92 (fiscal 2023); the current reading is higher than 18% of that period. Celanese Corporation ranks 3rd of 14 Chemicals companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | −$10.64 | — |
| FY2024 | −$13.93 | — |
| FY2023 | $17.92 | 3.34% |
| FY2022 | $17.34 | 2.85% |
| FY2021 | $16.86 | 0.66% |
| FY2020 | $16.75 | 144.88% |
| FY2019 | $6.84 | (23.23%) |
| FY2018 | $8.91 | 46.31% |
| FY2017 | $6.09 | (1.46%) |
| FY2016 | $6.18 | 209.00% |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Sep 2026 | $0.67 | (40.71%) |
| Jun 2026 | $1.13 | 182.50% |
| Mar 2026 | $0.40 | 135.29% |
| Dec 2025 | $0.17 | — |
| 43 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| REX REX American Resources Corporation compare | $3.65 |
| GPRE Green Plains, Inc. compare | $2.45 |
| CE Celanese Corporation | $2.37 |
| WLKP Westlake Chemical Partners LP compare | $1.67 |
| LXU Lsb Industries Inc. compare | $0.62 |
| VHI Valhi, Inc. compare | $0.05 |
| HUN Huntsman Corporation compare | −$0.93 |
| DOW Dow Inc. compare | −$1.28 |
| OLN Olin Corporation compare | −$1.97 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on CE
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement